Optimising patient centred drug development to realise impact.
Saved in:
| Title: | Optimising patient centred drug development to realise impact. |
|---|---|
| Authors: | Calvert M; Centre for Patient Reported Outcomes Research, Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk.; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk.; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk.; National Institute for Health and Care Research (NIHR) Applied Research Collaboration (ARC) West Midlands, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk.; NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk., Kamudoni P; Merck KGaA, Darmstadt, Germany., Yap C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Snyder C; Johns Hopkins Schools of Medicine and Public Health, Baltimore, MD, USA., Wilson R; Patient Member, Cancer Research Advocates Forum UK, London, UK., Aiyegbusi OL; Centre for Patient Reported Outcomes Research, Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK.; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK.; National Institute for Health and Care Research (NIHR) Applied Research Collaboration (ARC) West Midlands, University of Birmingham, Birmingham, UK.; NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, UK. |
| Source: | Communications medicine [Commun Med (Lond)] 2026 May 19; Vol. 6 (1). Date of Electronic Publication: 2026 May 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
